Skip to main content

InspireMD, Inc.

corporate_fare Company Profile

InspireMD, Inc.

NSPR·NASDAQ·Industrial Applications And Services·CIK 0001433607

We are a medical device company focused on developing and selling products for carotid artery disease and other vascular conditions. Our product line includes two commercial products based on our CGuard carotid stent technology, which aims to protect against embolisms during and after stenting procedures. A stent is an expandable metallic device placed in an artery to widen it and restore blood flow. Our first product, the CGuard Carotid Embolic Prevention System ("CGuard EPS"), combines a self-expanding nitinol stent with a MicroNet mesh sleeve into a single device for carotid artery revascularization. CGuard EPS received CE Mark recertification under the EU Medical Device Regulation ("MDR") in January 2024, having previously held CE Mark approval under the former Medical Device Directive ("MDD"). CGuard EPS is sold in over 30 countries outside the United States via distributors. Our second product, the CGuard Prime Carotid Stent System ("CGuard Prime"), uses the same stent and MicroNet mesh as CGuard EPS but with a different deployment mechanism. CGuard Prime received premarket approval ("PMA") from the U.S. Food and Drug Administration ("FDA") on June 23, 2025, and is sold exclusively in the United States by our direct salesforce. It also received MDR CE Mark approval on June 12, 2025. In October 2024, the FDA approved our Investigational Device Exemption (IDE) to begin the CGUARDIANS II pivotal study for the CGuard Prime 80 cm carotid stent system during transcarotid revascularization ("TCAR") procedures. We completed enrollment in the CGUARDIANS II pivotal study in the first quarter of 2026. In October 2023, the Centers for Medicare & Medicaid Services ("CMS") issued a final National Coverage Determination ("NCD"), which expanded coverage for both carotid artery stenting ("CAS") and TCAR procedures to include asymptomatic and standard risk patients.

InspireMD, Inc. (NASDAQ:NSPR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 31 items for NSPR at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • InspireMD Recalls CGuard Prime Delivery System, Withdraws 2026 Revenue Guidance Amidst Going Concern Warning
  • InspireMD CEO Discloses 5.18% Beneficial Ownership Stake
  • InspireMD Seeks Shareholder Approval for 100 Million Share Increase, Enabling Significant Future Dilution
  • InspireMD Seeks Shareholder Approval to Increase Authorized Shares by 100 Million, Enabling Substantial Future Dilution
  • InspireMD Replaces $75M ATM Program with New One, Signaling Massive Dilution Amidst Going Concern

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$8.98M
Net Income
-$48.79M
Diluted EPS
-$0.76
Op. Cash Flow
-$35.1M
Free Cash Flow
-$36.77M
Gross Profit
$2.65M
Operating Income
-$49.61M
Cash & Equivalents
$8.94M
Debt / Equity
0.00×
Net Margin
-5.43×
Shares Outstanding
43.53M sh
Source: 10-K · filed 2026-03-18 · accession 0001493152-26-010886
$0.508 -5.93% today
52-week range · as of 2026-11-20 $0.4254 – $2.17
Market cap
$29.23M
Volume
634K (1.6× avg)
3-mo avg 408.3K
Live data · 2026-11-22 03:38 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NSPR - Filings & News (Page 2)

NSPR
May 01, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $0.508 info
Change: -$0.982 (-66%) info
Market Cap: $29.229M info
NSPR
Apr 24, 2026, 5:00 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.25
Real-time Price: $0.508 info
Change: -$0.742 (-59%) info
Market Cap: $29.229M info
NSPR
Apr 20, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $1.35
Real-time Price: $0.508 info
Change: -$0.842 (-62%) info
Market Cap: $29.229M info
NSPR
Apr 10, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $1.29
Real-time Price: $0.508 info
Change: -$0.782 (-61%) info
Market Cap: $29.229M info
NSPR
Apr 03, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.54
Real-time Price: $0.508 info
Change: -$1.03 (-67%) info
Market Cap: $29.229M info
NSPR
Apr 03, 2026, 3:53 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.54
Real-time Price: $0.508 info
Change: -$1.03 (-67%) info
Market Cap: $29.229M info
NSPR
Mar 18, 2026, 8:34 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $2.05
Real-time Price: $0.508 info
Change: -$1.54 (-75%) info
Market Cap: $29.229M info
NSPR
Mar 18, 2026, 7:18 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.88
Real-time Price: $0.508 info
Change: -$1.37 (-73%) info
Market Cap: $29.229M info
NSPR
Mar 18, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $0.508 info
Change: -$1.49 (-75%) info
Market Cap: $29.229M info
NSPR
Mar 04, 2026, 5:20 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $0.508 info
Change: -$1.10 (-68%) info
Market Cap: $29.229M info
NSPR
Mar 04, 2026, 5:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $0.508 info
Change: -$1.10 (-68%) info
Market Cap: $29.229M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets